Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
34 studies found for:    CD44
Show Display Options
Rank Status Study
1 Recruiting Saliva-based Detection of CD44
Conditions: Oral Cavity Squamous Cell Carcinoma;   Oropharynx Squamous Cell Carcinoma;   Squamous Cell Carcinoma of the Oropharynx;   Squamous Cell Carcinoma of the Head and Neck
Intervention: Device: OncAlert
2 Completed A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors
Condition: Neoplasms
Intervention: Drug: RO5429083
3 Completed Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: bivatuzumab mertansine
4 Terminated Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: bivatuzumab mertansine
5 Unknown  Methylation Status of CD44 Promoter Region in Primary Lung Cancer
Condition: Non-Small Cell Lung Cancer
6 Recruiting A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours
Condition: Malignant Solid Tumor
Intervention: Drug: AMC303
7 Withdrawn Prognostic Value of Stem Cell Related Markers
Condition: Breast Cancer
8 Terminated Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   CLL;   SLL
Intervention: Drug: A6
9 Recruiting Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Condition: Ovarian Epithelial Cancer
Intervention: Drug: SPL-108
10 Unknown  Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
Condition: Lung Cancer
Intervention: Procedure: phlebotomy
11 Completed Vascular Access for Hemodialysis and Inflammation
Condition: Vascular Access for Hemodialysis and Inflammation
12 Active, not recruiting
Has Results
Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer
Conditions: Recurrent Pancreatic Carcinoma;   Stage IV Pancreatic Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Vismodegib
13 Completed
Has Results
GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
Conditions: Neoplasms, Oral;   Mouth Neoplasms
Intervention: Drug: GSK1120212
14 Unknown  Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Simvastatin
15 Terminated RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
16 Unknown  Effects of ADSC Therapy in Women With POF
Condition: Premature Ovarian Failure
Intervention: Procedure: Autologous fat grafting
17 Completed Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer
Conditions: HER2-positive Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Drug: lapatinib ditosylate;   Drug: paclitaxel;   Biological: trastuzumab;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
18 Recruiting To Study the Effect of Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy
Condition: Cancer Stem Cell
Intervention: Dietary Supplement: Fursultiamine
19 Recruiting 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
Conditions: Lung Carcinoma;   Solitary Pulmonary Nodule;   Cigarette Smoking Behavior
Interventions: Procedure: Computed Tomography;   Radiation: fluorodeoxyglucose F-18;   Drug: Fluorine F 18 L-glutamate Derivative BAY94-9392;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Procedure: Positron Emission Tomography (PET)
20 Completed Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
Condition: Asthma
Interventions: Drug: GSK2269557;   Drug: GSK2269557 matching placebo

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.